QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:
Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (10) Citing Articles via Google Scholar Google Scholar Articles by Perry, A. Search for Related Content PubMed PubMed Citation

Pathology of low-grade gliomas: An update of emerging concepts

Division of Neuropathology, Washington University School of Medicine, St. Louis, MO 63110, USA

¹ Address correspondence to Arie Perry, Division of Neuropathology, Box 8118, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110-1093, USA (aperry{at}pathology.wustl.edu)

Abstract

Although the term low-grade glioma (LGG) is useful for its connotation of a slow-growing, better prognosis CNS primary neoplasm typically occurring in a young patient, it also serves as a potential diagnostic wastebasket, occasionally leading to conceptual errors, therapeutic uncertainty, or misinterpretation of clinical data. For example, the LGG designation is occasionally invoked as a justification for lumping together biologically unrelated entities such as pilocytic astrocytoma and diffuse astrocytoma. Whereas the former represents a benign and potentially surgically curable neoplasm that virtually never undergoes malignant transformation, the latter is a surgically incurable low-grade malignancy, prone to further malignant progression and eventual fatality. Therefore, although rare cases lacking a clear distinction may be encountered, the term LGG should be abandoned for a more specific diagnosis whenever possible. The primary goals of this paper are to review practical surgical pathology issues related to the diagnosis of diffuse LGGs and to update the reader on emerging clinicopathologic and molecular genetic concepts. Also discussed are current controversies of classification/grading and the role of ancillary testing via immunohistochemical and genetic techniques.

This article has been cited by other articles:

				R. Bartha, J.F. Megyesi, and C.J. Watling Low-Grade Glioma: Correlation of Short Echo Time 1H-MR Spectroscopy with 23Na MR Imaging AJNR Am. J. Neuroradiol., March 1, 2008; 29(3): 464 - 470. [Abstract] [Full Text] [PDF]

				C F Parsa and S Givrad Pilocytic astrocytomas as hamartomas: implications for treatment Br. J. Ophthalmol., January 1, 2008; 92(1): 3 - 6. [Full Text] [PDF]

				C F Parsa and S Givrad Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas Br. J. Ophthalmol., January 1, 2008; 92(1): 40 - 46. [Abstract] [Full Text] [PDF]

				Z. Rumboldt, D.L.A. Camacho, D. Lake, C.T. Welsh, and M. Castillo Apparent Diffusion Coefficients for Differentiation of Cerebellar Tumors in Children AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1362 - 1369. [Abstract] [Full Text] [PDF]